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Abstract 
Objectives 
There is a lack of literature regarding the procedure-specific quality of acute postoperative pain management 
after midfacial fracture repair. The purpose of the presented prospective clinical study was to evaluate 
postoperative pain management after surgical repair of midfacial fractures. 
 
Materials and methods 
Eighty-five adults were evaluated on the first postoperative day following midfacial repair using the 
questionnaire of the Quality Improvement in Postoperative Pain Management (QUIPS) project. The main 
outcome measures were patients’ characteristics and clinical- and patient-reported outcome parameters. 
 
Results 
Overall, pain on the first postoperative day was moderate. A significant correlation between process and 
outcome parameters could be shown. Duration of surgery above the calculated median was significantly 
associated with higher maximum pain intensity (p = 0.017). Patients requiring opioids in the recovery room 
presented significantly higher pain on activity (p = 0.029) and maximum pain (p = 0.035). Sleeping impairment 
(p = 0.001) and mood disturbance (p = 0.008) were significantly more prevalent in patients undergoing repair of 
a centrolateral midfacial fracture. 
 
Conclusions 
QUIPS is a simple and qualified tool to evaluate the procedure specific quality of acute postoperative pain 
management. Pain on the first postoperative day following midfacial fracture repair seems overall to be 
moderate. Nearly a third of the patients showed inadequate postoperative pain management. To prevent 
inadequate postoperative pain management, it is necessary to establish a continued procedure-specific 
outcome measurement. 
Keywords 
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Clinical relevance 
Repair of a centrolateral midfacial fracture, long duration of surgery, and need of opioids in the recovery room 
seem to be associated with higher postoperative pain levels. 
Introduction 
Management of postoperative pain is part of the daily clinical routine of every maxillofacial surgeon. An 
adequate postoperative pain management is essential in the postoperative care and is an ethical obligation [1]. 
Poorly managed postoperative pain may lead to increased suffering, increased costs of care, and chronic pain [2, 
3]. 
 
However, there seems to be a worldwide undersupply of adequate postoperative pain medications [4, 5, 6]. 
Investigations from various countries confirm that the quality of acute pain management is unsatisfying [5, 7, 8, 
9, 10]. 
 
Over the last decade, several clinical guidelines were published, which helped to improve processes and 
structures of pain management, however, outcomes such as pain intensity did not [11, 12]. 
 
The efficiency of analgesic interventions varies widely between different procedures. Therefore, for optimal pain 
management, surgery-specific approaches should be considered [2]. 
 
Surgical repair of centrolateral and lateral midfacial fractures as well as isolated fractures of the orbital floor is a 
frequently and routinely performed procedure in every maxillofacial surgery department. Although it is of the 
biggest clinical interest to investigate postoperative pain, there is a lack of knowledge in the literature regarding 
procedure-specific and quality of pain management after midfacial fracture repair. 
 
The presented prospective clinical study investigates postoperative quality of pain management on the first 
postoperative day after midfacial fracture repair. A standardized assessment of patients’ characteristics, 
process, and outcome parameters of postoperative pain management was performed using the questionnaire of 
the Quality Improvement in Postoperative Pain Management (QUIPS) system. 
Patients and method 
The presented prospective study was performed at the Department of Maxillofacial Surgery/Plastic Surgery of 
the University Hospital Jena. Institutional review board approval (ethics committee of the University Hospital 
Jena at the Medical Faculty) was obtained before the study was initiated. 
 
Patients who underwent surgical repair of a lateral or centrolateral midfacial fracture or an isolated orbital floor 
fracture were included. Surgical approaches as well as reposition and osteosynthetic stabilization of fractures 
were performed in a standardized manner. The lateral and centrolateral midface were operated via a gingival 
approach, the lateral orbital rim via an upper eyelid and the orbital floor via a transconjunctival approach [13]. 
Local anesthesia in terms of 2 % lignocaine with 1:100,000 epinephrine (mibe GmbH, Brehna, Germany) was 
only injected in the area of the gingival approach. If necessary, alloplastic reconstruction of the orbital floor was 
performed by using a polydioxanone sheet (PDS, Ethicon Products, Norderstedt, Germany), in severe cases by a 
titanium mesh (Synthes, Umirch, Germany). Osteosynthetic stabilization was performed using mini-plates 
(sutura frontozygomatica, medial and lateral buttress) and micro-plates (inferior orbital rim) (Medartis, Basel, 
Switzerland). 
 
Patients received a postoperative nausea and vomiting prophylaxis according to their individual risk profile, 
using granisetron and dexamethasone. Anesthesia and pain treatment was performed according to hospital 
standards (premedication: midazolam; intraoperative analgesics: sufentanil and metamizole (dipyrone); 
postoperative analgesics: metamizole as routine treatment combined with piritramide on an as-needed basis; 
local cool packs). However, deviation from these standards was allowed to physicians’ discretion in case of 
allergies, patients’ preferences, and other reasons. 
 
Demographic and procedure-specific characteristics of each patient were recorded using a standardized and 
categorized database including, e.g., age, gender, body mass index (BMI), ASA status, and duration of surgery. 
The assessment of postoperative pain was performed at the first postoperative day not exceeding 24 h after 
surgery by a study nurse not being involved in the routine care of the patients. After a standardized instruction, 
the first part of the QUIPS questionnaire, which covers outcome parameters of postoperative pain management, 
was given to the patient. It was answered and completed by the patient him- or herself. Eleven-point numeric 
rating scales were used to evaluate the intensity of the parameter. In general, higher numbers indicate more 
pain (0 = no pain, 10 = maximal pain). Dichotomous questions were answered with yes or no. 
 
The second part of the questionnaire covered the relevant process parameters of postoperative pain 
management and was filled out by a study nurse. Data were collected without systematization of analgesic 
medication to record the postoperative pain treatment as it was done daily. All data were anonymized and 
transferred to the external database of QUIPS via Internet (http://www.quips-projekt.de). 
 
Postoperative pain medication was reduced and finally stopped when adequate analgesia and pain reduction 
was achieved. 
Statistical analysis 
If not indicated otherwise, data are presented as mean and standard deviation. Outcome and process 
parameters are given descriptively (Tables 1 and 2). The continuous variables age and duration of surgery were 
transformed into dichotomous variables using the median values as separator. Non-parametric Mann-Whitney 
U tests were applied to compare continuous variables between resulting independent subgroup pairs, Kruskal-
Wallis test was performed to compare results between multiple subgroups. Pearson’s Chi-square tests were 
applied to compare categorized data of independent subgroups (see Tables 3 and 4). In cases where 
requirements for Pearson’s Chi-square test were not met, Fisher’s Exact Test was applied. In cases where 
multiple groups were compared, nominal p values of two-tailed tests are reported. A value of p < 0.05 was taken 
to be significant. All calculations were conducted with SPSS Version 21.0 for Windows (SPSS, Inc, Chicago, IL). 
 
Table 1. QUIPS outcome parameters after midfacial fracture repair (n = 85 patients) 
Pain on activity 2.76 ± 1.986 
Maximum pain intensity 3.78 ± 2.701 
Maximum pain intensity 1.29 ± 1.379 
Satisfaction with pain intensity 12.25 ± 2.400 
Preoperative pain management counseling   
 Yes, only general 60 
 Yes, also specific 19 
 No 6 
Chronic pain before surgery   
 Yes 72 
 No 13 
Mobility impairment because of pain   
 Yes 61 
 No 24 
Breathing impairment because of pain   
 Yes 69 
 No 16 
Sleeping impairment because of pain   
 Yes 67 
 No 18 
Mood impairment because of pain   
 Yes 61 
 No 24 
Desire for pain medication   
 Yes 79 
 No 6 
Drowsiness since surgery   
 Yes 41 
 No 44 
 
Table 2. QUIPS process parameter after midfacial fracture repair (n = 85 patients) 
Sedative as premedication  
 Midazolam 81 
 No 4 
Non opioid intraoperative  
 Metamizole 79 
 Parecoxib 1 
 No 6 
Opioid intraoperative  
 Sufentanil 84 
 Remifentanil 5 
 Piritramide 5 
 No 1 
Prednisolone  
 Yes 79 
 No 6 
 PONV prophylaxis 59 
 Granisetron 44 
 Dexamethasone 25 
 MCP 0 
 Dimenhydrinal 0 
 No 26 
Clonidine perioperatively  
 Yes 3 
 No 82 
Non-opioid on ward  
 Metamizole 78 
 Paracetamol 1 
 Ibuprofen 5 
 No 5 
 Opioid on ward 0 
 
Table 3. Relation between process and outcome parameters concerning postoperative pain after midfacial 
fracture repair (Part 1) 
  Pain on 
activity 
(0–10) 
Maximum 
pain 
intensity 
(0–10) 
Minimum 
pain 
intensity 
(0–10) 
Satisfaction 
with pain 
intensity (0–
15) 
Mobility 
decreased 
(n) 
Breathing 
disturbance 
(n) 
Age 
(median = 59 years) 
0.101 0.237 0.653 0.587 1.000 0.785 
Gender 0.669 0.279 0.681 0.071 1.000 0.259 
BMI (≤25 vs. >25) 0.723 0.422 0.642 0.058 0.399 0.272 
ASA (I vs. II–III) 0.094 0.147 0.161 0.767 0.802 0.766 
Duration of surgery 
(median 
time = 65 min) 
0.081 0.017 0.196 0.488 0.056 0.102 
 <Median (n = 43)   3.1 ± 2.6         
 >Median (n = 42)   4.5 ± 2.6         
Counseling (specific 
vs. general vs. no) 
0.323 0.664 0.796 0.394 0.567 1.000 
Premedication 
midazolam 
0.543 0.457 0.461 0.368 0.554 1.000 
Sufentanil 
intraoperative 
1.000 0.882 0.859 0.706 1.000 1.000 
Clonidine 
perioperative 
0.674 0.993 0.643 0.658 0.555 0.470 
PONV prophylaxis 0.698 0.642 0.689 0.191 1.000 0.369 
Granisetron 0.329 0.159 0.098 0.956 0.479 0.169 
Dexamethasone 0.317 0.430 0.028 0.080 0.122 1.000 
 Yes (n = 60)     1.5 ± 1.4       
 No (n = 25)     0.8 ± 1.2       
Prednisolone 0.467 0.361 0.310 0.238 1.000 1.000 
Non-opioid 
intraoperative 
0.938 0.742 0.310 0.893 0.671 0.589 
Opioid intraoperative 1.000 0.882 0.859 0.706 1.000 1.000 
Opioid in recovery 
room 
0.029 0.035 0.078 0.497 0.213 0.775 
 Yes (n = 53) 2.4 ± 1.7 3.3 ± 2.6         
 No (n = 32) 3.4 ± 2.2 4.6 ± 2.8         
Non-opioid on ward 0.419 0.471 0.292 0.204 1.000 1.000 
Opioid on ward 0.181 0.224 0.381 0.190 0.540 0.726 
 
Table 4. Relation between process and outcome parameters concerning postoperative pain after midfacial 
fracture repair (Part 2) 
  Sleeping 
impairmen
t (n) 
Mood 
disturbanc
e (n) 
Desire for 
pain 
medicatio
n (n) 
Drowsines
s (n) 
Nause
a (n) 
Vomitin
g (n) 
Chronic 
pain 
preoperativ
e (n) 
Age 
(median = 59 year
s) 
0.433 0.238 0.204 1.000 1.000 1.000 0.232 
Gender 0.591 0.464 0.393 1.000 0.712 1.000 1.000 
BMI (≤25 vs. >25) 1.000 0.804 0.402 0.826 0.468 0.139 0.354 
ASA (I vs. II–III) 0.022 0.119 0.377 0.102 1.000 1.000 0.211 
 ASA I (n = 27) n = 10             
 ASA II–III 
(n = 58) 
n = 8             
Duration of 
surgery (median 
time = 65 min) 
0.117 0.056 0.676 1.000 1.000 0.241 0.228 
Counseling 
(specific vs. 
general vs. no) 
0.554 0.775 0.612 1.000 1.000 1.000 0.723 
Premedication 
midazolam 
0.520 1.000 1.000 0.603 1.000 1.000 1.000 
Sufentanil 
intraoperative 
0.212 0.282 1.000 0.482 1.000 1.000 1.000 
Clonidine 
perioperative 
1.000 0.555 1.000 0.607 1.000 1.000 1.000 
PONV prophylaxis 0.413 0.604 0.171 0.818 1.000 1.000 1.000 
Granisetron 0.190 0.479 0.204 0.829 0.147 0.230 1.000 
Dexamethasone 0.567 1.000 1.000 1.000 0.007 0.084 1.000 
 Yes (n = 60)         n = 2     
 No (n = 25)         n = 6     
Prednisolone 0.106 0.671 1.000 0.423 0.639 1.000 0.584 
Non-opioid 
intraoperative 
0.334 1.000 0.364 1.000 0.096 1.000 1.000 
Opioid 
intraoperative 
0.212 0.282 1.000 0.482 1.000 1.000 1.000 
Opioid in recovery 
room 
0.587 0.631 0.668 0.072 0.468 1.000 0.223 
Non-opioid on 
ward 
0.579 0.315 1.000 0.361 0.398 1.000 0.573 
Opioid in the ward 0.293 0.344 0.065 1.000 0.626 1.000 0.448 
Results 
A total of 85 patients were enrolled during the study period of 6 months (April to September 2013). Fifty 
(58.8 %) patients were males and 35 (41.2 %) females. Mean age was 56.2 ± 20.7 years at time of evaluation. 
Mean body height and mean body weight was 172.3 ± 9.3 cm and 73.3 ± 14.6 kg, respectively. Thirteen patients 
(15.3 %) regularly used pain medicaments for pre-existing chronic pain related to other diseases. Twenty-seven 
(31.8 %) patients were classified under ASA 1, 43 (50.6 %) ASA 2, and 15 (17.6 %) ASA 3. 
 
Forty-four (51.8 %) patients showed a lateral midfacial fracture, 21 (24.7 %) a centrolateral midfacial fracture 
and 20 (23.5 %) an isolated orbital floor fracture. Mean duration of surgery was 82.9 ± 57.4 min. 
 
Results of the QUIPS questionnaire regarding the patient-reported outcome parameters are given in Table 1. 
Minimal pain was on average 1.29 ± 1.38 on the 11-step Numeric Rating Scale (NRS). Strain-related pain 
increased to 2.76 ± 1.99. Maximum pain levels showed a mean of 3.78 ± 2.70. Overall, satisfaction with pain 
therapy was very high. Only 19 (22.4 %) of the patients reported to have received preoperative pain counseling. 
 
Concerning pain-related complaints, nearly a quarter of the patients reported pain-related impairment of 
mobility and disturbance of mood. Nearly every fifth patient reported impairment of breathing and sleeping. 
Only six (7.1 %) patients desired more pain medication. Eight (9.4 %) patients reported postoperative nausea 
and two (2.4 %) vomiting. 
 
Details of the pain management performed are given in Table 2. The standard sedative for premedication was 
midazolam. Intraoperatively, nearly all patients received sufentanil and metamizol. Clonidine was rarely applied. 
When a gingival approach was performed, patients received local anesthesia using 2 % lignocaine with 
1:100,000 epinephrine (mibe GmbH, Germany). Prophylaxis of postoperative nausea and vomiting (PONV) was 
performed in nearly half of the patients by granisetron and in a quarter of the patients by dexamethasone. 
 
In the recovery room, 32 (37.6 %) patients received opioids, of which 31 (96.9 %) received piritramide. The other 
patients did not require additional pain medication. 
 
In the ward, 91.8 % of the patients received metamizol applied in a dosage of 4 × 1 g. None of the patients were 
given additional opioids in the ward. All patients received cold packs as physical pain therapy. Written individual 
instructions for pain therapy and routine pain documentation were recorded in all patients. 
 
Relations between the above-described outcome and process parameters are given in Tables 3 and 4. Patients 
exhibiting an American Society of Anesthesiologists (ASA) status of 1 reported significantly more often sleeping 
impairment (p = 0.022). Duration of surgery above the calculated median of 65 min was related with significantly 
higher postoperative maximal pain (p = 0.017). Patients receiving dexamethasone showed significantly less 
minimal pain (p = 0.028) but presented more often postoperative nausea (p = 0.007). Those 32 patients that 
received opioids in the recovery room presented significantly higher levels of strain-related pain (p = 0.029) and 
higher maximal pain levels (p = 0.035). 
 
The type of midfacial fracture showed a significant interference with the categorized data of sleeping (p = 0.001) 
and mood (p = 0.008) in a multivariate analysis. The type of fracture did not significantly influence pain intensity. 
Pearson’s Chi-square was used to analyse associations within the subgroups. After repair of a centrolateral 
midfacial fracture, significantly more patients exhibited sleeping impairment compared to lateral midfacial 
fractures (p = 0.001) and orbital floor fractures (p = 0.006). Also, impairment of mood was significantly more 
often reported when a centrolateral midfacial fracture was repaired compared to lateral midfacial fractures 
(p = 0.048) and orbital floor fractures (p = 0.006). There was no significant difference between lateral midfacial 
fractures and orbital floor fractures. 
Discussion 
Inadequate postoperative pain results in patient discomfort and may decrease patient satisfaction [14]. It may 
even increase the risk for pulmonary and cardiovascular complications and also contribute to the risk of 
development of chronic pain. Thus, adequate pain management is an essential part of postoperative care [15, 
16, 17]. 
 
Intraoperatively as well as in the recovery room, pain management is controlled by anesthesiologists, whereas 
surgeons are responsible for the postoperative recovery and pain management in the ward. 
 
Currently, it is an almost ubiquitous phenomenon that postoperative pain management especially in the ward is 
insufficient. The main reasons for insufficient pain management are not attributed to medical problems; 
numerous studies regarding the appropriate technique in analgesic treatment are available. There are 
indications that insufficient postoperative pain management is associated with inadequate exploitation of 
existing knowledge among health care professionals and patients, lack of institutional commitment, regulatory 
concerns, and limited access to and reimbursement for interdisciplinary care 2, 18, 19]. 
 
Currently, surgeons regularly seek advice on principles for postoperative pain management in general guidelines 
for acute pain management or in major textbooks [2]. The recommendations of these guidelines and books are 
predominately based on studies in poorly defined surgical procedures [2]. The same applies to the published 
postoperative pain management guideline for the head and neck area [20]. 
 
This is of special interest to the maxillofacial surgeon as there are hints for a large variation in the intensity and 
character of pain after different types of head and neck surgery. E.g., it has been shown that patients 
undergoing surgery of the oral region, pharynx, larynx, neck, and salivary glands had a 4 to 10 times higher risk 
of intense postoperative pain compared to patients undergoing ear surgery [15]. Thus, it is of special interest for 
maxillofacial surgeons to perform further investigations to optimize the outcome of acute postoperative pain 
management. 
 
In the presented study, we evaluated the quality of acute postoperative pain management after midfacial 
fracture repair, which is one of the most frequently performed standardized procedures in nearly all 
maxillofacial departments, using QUIPS. 
 
In other disciplines of surgery, QUIPS has already been shown helpful to significantly improve postoperative pain 
management quality [21, 24]. 
 
Despite the presented qualities of QUIPS like standardized data acquisition with validated questionnaires and 
independent and trained staff performing the interviews, some limitations have to be mentioned: a limitation of 
our study is that the application of QUIPS does not allow conclusions about the further course of postoperative 
pain after the first postoperative day. Because normally pain decreases after the first postoperative day, it might 
be assumed that the postoperative pain therapy reported here is effective over the first postoperative day [15]. 
Another limitation is the absence of preoperative pain assessment. Thus, we could not differentiate between 
disease-caused and surgically induced pain. Furthermore, the presented data have a monocentric character. 
Thus, it is not possible to deduce from our data on a general situation. Also, a Hawthorne effect, describing 
unexpected and unexplained reactivity to experimentation in human subjects who are aware of their 
participation in a study, cannot be excluded. Usually, a Hawthorne effect improves rather than deteriorates 
study outcomes. 
 
Regarding the presented results of our study, minimal and maximal as well as pain on activity on the first 
postoperative day may be considered as moderate. On the 11-step NRS, pain ranged from 1.5 to 4.2. This rating 
is supported by the high level of patients’ satisfaction with the postoperative analgesic treatment and the low 
number of patients reporting wish for more pain medication. In comparison to earlier reported maximum pain 
levels in osteosynthetic repair of a forearm fracture (5.8), patients showed less pain [21]. 
 
Regarding the investigated relations between process and outcome parameters, the duration of surgery 
presented a significant influence on postoperative maximum pain intensity. Patients exhibiting a duration of 
surgery above the median of 65 min showed significantly higher pain levels in contrast to patients with shorter 
surgeries (p = 0.017). Higher duration of surgery may be interpreted as a hint on a complicated, very dislocated 
fracture requiring extensive preparation, exposure, and manipulation leading to a bigger surgical-induced 
trauma and higher levels of postoperative maximum pain. 
 
An association between extent of surgical trauma and patient-reported outcomes is further supported by the 
observation of significantly higher rate of sleeping impairment and mood disturbance in centrolateral midfacial 
fractures compared to lateral midfacial fractures and orbital floor fractures. Repair of centrolateral midfacial 
fractures mostly requires more surgical manipulation, e.g., an extended reduction and additional osteosynthesis 
of the medial buttress, possibly resulting in the reported differences in pain-related impairment. Despite these 
facts and the given observations, we did not detect significantly higher pain levels in patients presenting with 
centrolateral fractures. 
 
Application of dexamethasone to prevent PONV led to significantly lower levels of minimum pain (p = 0.028). 
This observation may be related to the antiphlogistic potency of dexamethasone. The higher rate of 
postoperative nausea in patients receiving dexamethasone may be related to higher anamnestic risk of PONV 
and consecutive medication with dexamethasone. In general, the application of corticosteroids to reduce 
postoperative swelling is part of a controversial discussion in the literature. 
 
Of special interest were the observed significantly higher levels of postoperative pain on activity (p = 0.029) and 
maximum pain (p = 0.035) in patients receiving opioids in the recovery room. Higher pain intensity in patients 
receiving opioids in the recovery room compared to those without opioid medication might be explained by the 
fact that opioid treatment was done on an as-needed base, i.e., those patients with higher pain intensity 
requested (and received) more opioids than those with less pain in the recovery room. 
 
On first sight, this seems as a contradiction to the strong analgesic effect of opioids and the higher amount of 
analgesics received by those patients. We think that the right interpretation of this observation needs to 
consider two facts: first, patients were asked for their maximum pain levels, when the effect of opioids of the 
recovery room (normally piritramide) had ended. Second, none of the patients, including those requiring opioids 
in the recovery room, received opioids in the ward. Most patients received metamizole (91.8 %), or ibuprofen 
(5.9 %) (see Table 2). This is an indication that the need of opioids in the recovery room should lead to 
application of opioids in the ward to prevent significant increase of maximum pain. 
 
Indeed non-opioids are considered as standard medication with oral and fast application after surgery to reduce 
postoperative pain to a minimum. This is in accordance with the current literature and current guidelines [25]. 
 
But despite these facts, 28 patients (32.9 %) presented severe pain with NRS values exceeding levels of ≥4 which 
indicates inadequate pain management. These patients maybe would have profited from an additional 
medication with opioids. Given this interpretation, we have to acknowledge that also on our ward nearly a third 
of our patients were undersupplied with adequate pain medication, especially opioids, which is a worldwide 
phenomenon [4, 5, 6]. Therefore, each pain management concept should comprise escalating steps in case of 
inadequately controlled pain, e.g., by the additional dispensation of opioids on an as-needed basis and/or use of 
patient-controlled analgesia (PCA) devices. Furthermore, the preoperative use of NSAIDs could be considered as 
it is recommended before third molar surgery and after other types of operation affecting bones and joints. The 
QUIPS project might be helpful to identify these deficits and correct it by sensitizing staff to use opioids more 
frequently and earlier, especially in patients requiring opioids in the recovery room. 
 
To our opinion, QUIPS has been shown to be an effective and practical instrument to measure postoperative 
pain after specific surgical procedures like midfacial fracture repair. Further improvement of acute postoperative 
pain management requires continued monitoring of the outcome of the analgesic treatment. 
Conclusion 
In an investigation of the outcome of postoperative acute pain management after midfacial repair using QUIPS, 
overall observed pain intensities were moderate. Analysis of process and outcome parameters revealed that 
inadequate pain management was prevalent especially in patients exhibiting duration of surgery above the 
median and patients requiring opioids in the recovery room. The application of QUIPS has shown adequate 
results to rate the outcome of acute postoperative pain management. 
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